Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks: Update and commentary
| Autor: | Yuan Yu Michael Huang, Sylvia Hsu |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
business.industry Antibodies Monoclonal Dermatology Antibodies Monoclonal Humanized medicine.disease 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Antibodies monoclonal 030220 oncology & carcinogenesis Psoriasis medicine Humans Secukinumab business |
| Zdroj: | Journal of the American Academy of Dermatology. 76:e221 |
| ISSN: | 0190-9622 |
| DOI: | 10.1016/j.jaad.2017.02.016 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect